Rights and permissions
About this article
Cite this article
Can we afford to ignore the newer anticonvulsants?. Pharmacoecon. Outcomes News 180, 3 (1998). https://doi.org/10.1007/BF03277744
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277744